Digital Pathology Market

Digital Pathology Market by Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End-User (Pharmaceutical Companies, Hospitals) - Global Forecast to 2025

Report Code: HIT 2608 Oct, 2020, by marketsandmarkets.com

[210 Pages Report] The global digital pathology market is projected to reach USD 1,054 million by 2025 from USD 553 million in 2020, at a CAGR of 13.8% during the forecast period. The growth of this market is majorly attributed to the increasing adoption of digital pathology to enhance lab efficiency, the rising prevalence of cancer, and the growing application of digital pathology in drug development & companion diagnostics. However, a lack of trained pathologists is expected to challenge market growth in the coming years.

Digital Pathology Market

To know about the assumptions considered for the study, Request for Free Sample Report

Covid-19 Impact on the Digital Pathology Market

The current COVID-19 pandemic has resulted in a massive number of patients visiting healthcare facilities on a daily basis. According to WHO data, there were 39.9 million confirmed COVID-19 cases and 1.1 million deaths globally, as of October 19, 2020. Due to the COVID-19 outbreak, the number of pathological tests conducted globally has decreased. Additionally, the lockdowns and restrictions implemented globally has negatively affected the demand for these solutions in 2020. However, the FDA approval for the use of digital pathology solutions for primary diagnostic purposes is expected to increase the demand during the forecast period. Thus, the need for better remote access to assess the patient’s diagnostic tests is expected to increase the demand for digital pathology solutions in the coming five years./

Digital Pathology Market Dynamics

Driver: Increasing adoption of digital pathology to enhance lab efficiency

Digital pathology helps improve lab efficiency by reducing costs, decreasing turnaround times, and providing users with access to subject-matter expertise. Improvements in lab efficiency are critical as patients and physicians are dependent on lab results for diagnostic decisions, and diagnostic tests are required to be completed and reported quickly and accurately. Moreover, access to digital slides via web services eliminates shipping costs and pathologists’ travel time. The outbreak of the COVID-19 pandemic has led to the implementation of lockdowns and social distancing restrictions. Such restrictions have increased the demand for digital pathology solutions, as these can be used by pathologists to remotely view diagnostic results for primary diagnosis. In order to gain a competitive edge and deliver quick services, a large number of pathologists and pathology labs are adopting digital pathology.

Restraints: High cost of digital pathology systems

Although large hospitals with significant capital budgets can afford these systems, pathologists and academic institutes with limited budgets or IT support often cannot afford them. The high cost of these systems, coupled with a dearth of skilled personnel to operate digital pathology systems, is expected to limit the adoption of these systems.

Opportunities: Introduction of affordable scanners for private pathology practices

The development of affordable scanners is expected to offer growth opportunities for players operating in the digital pathology market. Most private medical practices are small businesses and cannot afford expensive digital pathology systems. The introduction of affordable scanners will encourage their adoption among pathologists with low or limited budgets.

Challenges:Lack of trained pathologists

Pathologists play a crucial role in performing laboratory tests essential for disease diagnosis. However, at present, there is a gap between the supply and demand of pathologists worldwide, especially in countries in the Asia Pacific and Africa. Thus, the alarming shortage of pathologists is expected to result in the increased utilization of digital pathology for providing remote pathological consultation and services.

The scanners segment accounted for the largest share of the digital pathology market, by product, in 2019

On the basis of product, the digital pathology market is segmented into scanners, software, communication systems, and storage systems. The scanners segment accounted for the largest share of the global digital pathology market in 2019. The large share of this segment can be attributed to the increasing adoption of digital pathology solutions across the globe.

By application, the drug discovery segment accounted for the largest market share in 2019

On the basis of application, the digital pathology market is segmented into drug discovery, disease diagnosis, teleconsultation, and training & education. The drug discovery segment accounted for the largest share of the global digital pathology market, by application, in 2019. The large share of this segment can be attributed to the growth in R&D expenditure, fueled by the need for numerous preclinical and clinical studies performed during the drug discovery and development process.

By end user, the pharmaceutical & biotechnologies segment to witness the highest growth during the forecast period

On the basis of end users, the global digital pathology market is broadly segmented into pharmaceutical & biotechnology companies, hospitals and reference laboratories, and academic & research institutes. The pharmaceutical & biotechnology companies segment accounted for the largest share of the global digital pathology market in 2019. The large share of this segment can be attributed to the increasing use of digital pathology for drug discovery studies and drug toxicology testing.

Digital Pathology Market  by Region

To know about the assumptions considered for the study, download the pdf brochure

North America dominates the digital pathology market, by region, in 2019

North America accounted for the largest share of the digital pathology market in 2019. The large share of this region in the global digital pathology market can be attributed to the increasing prevalence of cancer, rising demand for quality diagnostics, the introduction of favorable reimbursement policies, and the implementation of favorable initiatives by the government in the US and Canada. The North American market is also expected to grow at the highest rate during the forecast period.

Key Market Players

The major players in the global digital pathology market are Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands), Hamamatsu Photonics (Japan). Other prominent players in this market include Roche (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN (US), Huron Digital Pathology (Canada), Visiopharm A/S (Denmark), Corista (US), Indica Labs (US), Objective Pathology Services (Canada), Sectra AB (Sweden), OptraSCAN (India), Glencoe Software (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD (China), Inspirata, Inc. (US), Mikroscan Technologies (US), Proscia Inc. (US), Kanteron Systems (Spain).

Scope of the Report:

Report Metric

Details

Market size available for years

2018–2024

Base year considered

2019

Forecast period

2020–2025

Forecast units

Value (USD Million)

Segments covered

Product, type, application, end-user, and region

Geographies covered

North America, Europe, Asia, and the Rest of the World

Companies covered

Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands), and Hamamatsu Photonics K.K. (Japan), Roche (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN (US), Huron Digital Pathology (Canada), Visiopharm A/S (Denmark), Corista (US), Indica Labs (US), Objective Pathology Services (Canada), Sectra AB (Sweden), OptraSCAN (India), Glencoe Software (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD (China), Inspirata Inc. (US), Mikroscan Technologies (US), Proscia Inc. (US), and Kanteron Systems (Spain).

The research report categorizes the digital pathology market into the following segments and subsegments:

Product

  • Scanners
  • Software
  • Communication Systems
  • Storage Systems

Type

  • Human Pathology
  • Veterinary Pathology

Application

  • Drug Discovery
  • Disease Diagnosis
  • Teleconsultation
  • Training & Education

End User

  • Pharmaceutical & Biotechnology Companies
  • Hospitals and Reference Laboratories
  • Academic & Research Institutes

Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Recent Developments

  • In 2019, Leica Biosystems (US) launched the Aperio GT 450
  • In 2019, F. Hoffmann-La Roche Ltd (Switzerland) launched the uPath enterprise software
  • In 2019, XIFIN (US) launched VisualStrata

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 20)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 25)
    2.1 RESEARCH DATA
           FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 2 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Breakdown of primary sources
                               FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY CATEGORY, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
           FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
           FIGURE 5 ILLUSTRATIVE EXAMPLE OF LEICA BIOSYSTEMS (SUBSIDIARY OF DANAHER CORPORATION)
           FIGURE 6 SUPPLY-SIDE ANALYSIS: DIGITAL PATHOLOGY MARKET (2019)
           FIGURE 7 BOTTOM-UP APPROACH
           FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
           FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE DIGITAL PATHOLOGY MARKET (2020-2025)
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
           FIGURE 10 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ESTIMATION
    2.5 ASSUMPTIONS FOR THE STUDY
    2.6 COVID-19 HEALTH ASSESSMENT
    2.7 COVID-19 ECONOMIC ASSESSMENT
           2.7.1 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
    2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO PERTAINING TO THE DIGITAL PATHOLOGY MARKET

3 EXECUTIVE SUMMARY (Page No. - 40)
    FIGURE 13 DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
    FIGURE 14 DIGITAL PATHOLOGY MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
    FIGURE 15 DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
    FIGURE 16 DIGITAL PATHOLOGY MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
    FIGURE 17 GEOGRAPHICAL SNAPSHOT OF THE DIGITAL PATHOLOGY MARKET

4 PREMIUM INSIGHTS (Page No. - 44)
    4.1 DIGITAL PATHOLOGY MARKET OVERVIEW
           FIGURE 18 RISING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH
    4.2 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT AND COUNTRY (2019)
           FIGURE 19 SCANNERS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN DIGITAL PATHOLOGY MARKET IN 2019
    4.3 DIGITAL PATHOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
           FIGURE 20 UK AND CHINA TO WITNESS THE HIGHEST GROWTH IN THE DIGITAL PATHOLOGY MARKET DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 47)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           TABLE 1 MARKET DYNAMICS: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Increasing adoption of digital pathology to enhance lab efficiency
                    5.2.1.2 Rising prevalence of cancer
                               TABLE 2 GLOBAL CANCER INCIDENCE, 2018 VS. 2025
                    5.2.1.3 Growing applications of digital pathology in drug development and companion diagnostics
                    5.2.1.4 Increasing initiatives by industry players
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of digital pathology systems
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Introduction of affordable scanners for private pathology practices
                    5.2.3.2 Increasing demand for personalized medicine
                               TABLE 3 GROWTH IN THE NUMBER OF PERSONALIZED MEDICINES, 2008–2016
                    5.2.3.3 High growth opportunities in emerging economies
           5.2.4 CHALLENGES
                    5.2.4.1 Lack of trained pathologists
                               TABLE 4 NUMBER OF PATHOLOGISTS PER 100,000 POPULATION, BY COUNTRY, 2018
    5.3 COVID-19 IMPACT ANALYSIS
           5.3.1 IMPACT OF COVID-19 ON THE DIGITAL PATHOLOGY MARKET
                    FIGURE 21 IMPACT OF COVID-19 ON THE DIGITAL PATHOLOGY MARKET
    5.4 ECOSYSTEM MARKET MAP
           FIGURE 22 DIGITAL PATHOLOGY MARKET: ECOSYSTEM MARKET MAP
    5.5 TRENDS IN AVERAGE SELLING PRICE
           FIGURE 23 DIGITAL PATHOLOGY MARKET: AVERAGE REGIONAL PRICES OF DIGITAL PATHOLOGY SCANNERS
    5.6 IMPACT OF THE NEW IVD REGULATION ON DIFFERENT MARKETS
           FIGURE 24 TIMELINE AND TRANSITION TO NEW MDR AND IVDR
           5.6.1 IMPACT ON CLINICAL LAB SERVICES
           5.6.2 IMPACT ON IVD
           5.6.3 IMPACT ON DIGITAL PATHOLOGY
    5.7 TECHNOLOGY ANALYSIS
           5.7.1 AI IN DIGITAL PATHOLOGY
                    TABLE 5 DIGITAL PATHOLOGY AI MARKET, BY REGION, 2018–2025 (USD MILLION)
    5.8 PATENT ANALYSIS
           5.8.1 METHODOLOGY
           5.8.2 PUBLICATION TRENDS
                    FIGURE 25 PUBLICATION TRENDS, 2015–2020
           5.8.3 JURISDICTION ANALYSIS
                    FIGURE 26 JURISDICTION ANALYSIS, 2015–2020
           5.8.4 TOP APPLICANTS
                    FIGURE 27 TOP APPLICANTS, 2015–2020

6 DIGITAL PATHOLOGY MARKET, BY PRODUCT (Page No. - 62)
    6.1 INTRODUCTION
           TABLE 6 DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
    6.2 SCANNERS
           6.2.1 SCANNERS ACCOUNTED FOR THE LARGEST SHARE OF THE DIGITAL PATHOLOGY PRODUCTS MARKET IN 2019
                    TABLE 7 SCANNING MAGNIFICATION AND APPLICATIONS
                    TABLE 8 DIGITAL PATHOLOGY SCANNERS OFFERED BY KEY MARKET PLAYERS
                    TABLE 9 DIGITAL PATHOLOGY SCANNERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    TABLE 10 DIGITAL PATHOLOGY SCANNERS MARKET, BY REGION, 2018–2025 (USD MILLION)
                    TABLE 11 DIGITAL PATHOLOGY SCANNERS MARKET, BY REGION, 2018–2025 (UNITS)
                    TABLE 12 DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           6.2.2 BRIGHTFIELD SCANNERS
                    TABLE 13 DIGITAL PATHOLOGY BRIGHTFIELD SCANNERS OFFERED BY KEY MARKET PLAYERS
                    TABLE 14 BRIGHTFIELD SCANNERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.2.3 FLUORESCENCE SCANNERS
                    TABLE 15 DIGITAL PATHOLOGY FLUORESCENCE SCANNERS OFFERED BY KEY MARKET PLAYERS
                    TABLE 16 FLUORESCENCE SCANNERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.2.4 OTHER DIGITAL PATHOLOGY SCANNERS
                    TABLE 17 OTHER DIGITAL PATHOLOGY SCANNERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    6.3 SOFTWARE
           6.3.1 DIGITAL PATHOLOGY SOFTWARE OFFERS ANALYTICAL AND HIGHLY ADVANCED FUNCTIONS NOT OFFERED BY TRADITIONAL MICROSCOPES
                    TABLE 18 DIGITAL PATHOLOGY SOFTWARE OFFERED BY KEY MARKET PLAYERS
                    TABLE 19 DIGITAL PATHOLOGY SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    TABLE 20 DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
           6.3.2 INFORMATION MANAGEMENT SOFTWARE
                    TABLE 21 INFORMATION MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.3.3 IMAGE ANALYSIS SOFTWARE
                    TABLE 22 IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.3.4 VISUALIZATION SOFTWARE
                    TABLE 23 VISUALIZATION SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    6.4 COMMUNICATION SYSTEMS
           6.4.1 INTRODUCTION OF CLOUD-BASED COMMUNICATION SYSTEMS PROVIDES IMPETUS TO MARKET GROWTH
                    TABLE 24 COMMUNICATION SYSTEMS USED IN DIGITAL PATHOLOGY
                    TABLE 25 DIGITAL PATHOLOGY COMMUNICATION SYSTEMS OFFERED BY KEY MARKET PLAYERS
                    TABLE 26 DIGITAL PATHOLOGY COMMUNICATION SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    6.5 STORAGE SYSTEMS
           6.5.1 NEED FOR STORING HIGH-QUALITY IMAGES IN A SAFE AND RELIABLE FORM TO DRIVE MARKET GROWTH
                    TABLE 27 DIGITAL PATHOLOGY STORAGE SYSTEMS OFFERED BY KEY MARKET PLAYERS
                    TABLE 28 DIGITAL PATHOLOGY STORAGE SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)

7 DIGITAL PATHOLOGY MARKET, BY TYPE (Page No. - 79)
    7.1 INTRODUCTION
           TABLE 29 DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
    7.2 HUMAN PATHOLOGY
           7.2.1 HUMAN PATHOLOGY SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD
                    TABLE 30 HUMAN DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    7.3 VETERINARY PATHOLOGY
           7.3.1 VETERINARY DIGITAL PATHOLOGY CUTS THE TURNAROUND TIME FOR ANIMAL DISEASE DIAGNOSIS—A KEY FACTOR DRIVING MARKET GROWTH
                    TABLE 31 VETERINARY DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)

8 DIGITAL PATHOLOGY MARKET, BY APPLICATION (Page No. - 83)
    8.1 INTRODUCTION
           TABLE 32 DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
    8.2 DRUG DISCOVERY
           8.2.1 INCREASING R&D SPENDING WILL PROVIDE IMPETUS TO MARKET GROWTH
                    TABLE 33 APPLICATIONS OF DIGITAL PATHOLOGY IN DRUG DISCOVERY/RESEARCH
                    TABLE 34 DIGITAL PATHOLOGY MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2018–2025 (USD MILLION)
    8.3 DISEASE DIAGNOSIS
           8.3.1 DISEASE DIAGNOSIS SEGMENT TO REGISTER STEADY GROWTH DURING THE FORECAST PERIOD
                    TABLE 35 DIGITAL PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY COUNTRY, 2018–2025 (USD MILLION)
    8.4 TELECONSULTATION
           8.4.1 THE NEED FOR ACCURATE, EFFICIENT, AND QUICK DIAGNOSIS IS EXPECTED TO DRIVE THE TELECONSULTATION MARKET DURING THE FORECAST PERIOD
                    TABLE 36 DIGITAL PATHOLOGY MARKET FOR TELECONSULTATION, BY COUNTRY, 2018–2025 (USD MILLION)
    8.5 TRAINING & EDUCATION
           8.5.1 DIGITAL PATHOLOGY CAN IMPROVE EDUCATION AND TRAINING PROVIDED TO PATHOLOGISTS
                    TABLE 37 DIGITAL PATHOLOGY MARKET FOR TRAINING & EDUCATION, BY COUNTRY, 2018–2025 (USD MILLION)

9 DIGITAL PATHOLOGY MARKET, BY END USER (Page No. - 90)
    9.1 INTRODUCTION
           TABLE 38 DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
           TABLE 39 DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018–2025 (USD MILLION)
           TABLE 40 DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018–2025 (UNITS)
    9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
           9.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST & FASTEST-GROWING END USERS OF THE DIGITAL PATHOLOGY MARKET
                    TABLE 41 DIGITAL PATHOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
                    TABLE 42 DIGITAL PATHOLOGY SCANNERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (USD MILLION)
                    TABLE 43 DIGITAL PATHOLOGY SCANNERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (UNITS)
    9.3 HOSPITALS & REFERENCE LABORATORIES
           9.3.1 INCREASING ADOPTION OF DIGITAL PATHOLOGY SOLUTIONS IN HOSPITALS TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
                    TABLE 44 HOSPITAL DEPLOYMENT OF DIGITAL PATHOLOGY SOLUTIONS
                    TABLE 45 DIGITAL PATHOLOGY MARKET FOR HOSPITALS & REFERENCE LABORATORIES, BY COUNTRY, 2018–2025 (USD MILLION)
                    TABLE 46 DIGITAL PATHOLOGY SCANNERS MARKET FOR HOSPITALS & REFERENCE LABORATORIES, BY REGION, 2018–2025 (USD MILLION)
                    TABLE 47 DIGITAL PATHOLOGY SCANNERS MARKET FOR HOSPITALS & REFERENCE LABORATORIES, BY REGION, 2018–2025 (UNITS)
    9.4 ACADEMIC & RESEARCH INSTITUTES
           9.4.1 ACADEMIC & RESEARCH INSTITUTES SEGMENT TO REGISTER STEADY GROWTH DURING THE FORECAST PERIOD
                    TABLE 48 DIGITAL PATHOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION)
                    TABLE 49 DIGITAL PATHOLOGY SCANNERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION)
                    TABLE 50 DIGITAL PATHOLOGY SCANNERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018–2025 (UNITS)

10 DIGITAL PATHOLOGY MARKET, BY REGION (Page No. - 100)
     10.1 INTRODUCTION
               FIGURE 28 DIGITAL PATHOLOGY MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)
               TABLE 51 DIGITAL PATHOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
     10.2 NORTH AMERICA
               FIGURE 29 NORTH AMERICA: DIGITAL PATHOLOGY MARKET SNAPSHOT
               TABLE 52 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
               TABLE 53 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
               TABLE 54 NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
               TABLE 55 NORTH AMERICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
               TABLE 56 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
               TABLE 57 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
               TABLE 58 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
               TABLE 59 NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018–2025 (USD MILLION)
               TABLE 60 NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018–2025 (UNITS)
             10.2.1 US
                       10.2.1.1 Favorable reimbursement scenario for digital pathology in the US
                                   TABLE 61 US: CANCER CASES, 2018
                                   TABLE 62 CONFERENCES/MEETINGS/COURSES/WORKSHOPS HELD/TO BE HELD IN THE US
                                   TABLE 63 US: KEY MACROINDICATORS
                                   TABLE 64 US: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                   TABLE 65 US: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 66 US: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 67 US: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 68 US: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                                   TABLE 69 US: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.2.2 CANADA
                       10.2.2.1 Growing need for high-quality cancer diagnosis and government initiatives to drive the market growth in Canada
                                   TABLE 70 CANADA: DIGITAL PATHOLOGY INITIATIVES AND FUNDING
                                   TABLE 71 CANADA: KEY MACROINDICATORS
                                   TABLE 72 CANADA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                   TABLE 73 CANADA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 74 CANADA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 75 CANADA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 76 CANADA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                                   TABLE 77 CANADA: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025(USD MILLION)
     10.3 EUROPE
               FIGURE 30 EUROPE: DIGITAL PATHOLOGY MARKET SNAPSHOT
               TABLE 78 EUROPE: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
               TABLE 79 EUROPE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
               TABLE 80 EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
               TABLE 81 EUROPE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
               TABLE 82 EUROPE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
               TABLE 83 EUROPE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
               TABLE 84 EUROPE: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
               TABLE 85 EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018–2025 (USD MILLION)
               TABLE 86 EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018–2025 (UNITS)
             10.3.1 UK
                       10.3.1.1 The UK is the largest market for digital pathology in Europe
                                   TABLE 87 CONFERENCES/COURSES HELD/TO BE HELD IN THE UK
                                   TABLE 88 UK: KEY MACROINDICATORS
                                   TABLE 89 UK: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                   TABLE 90 UK: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 91 UK: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 92 UK: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 93 UK: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                                   TABLE 94 UK: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.3.2 GERMANY
                       10.3.2.1 High healthcare expenditure and supportive health insurance to drive market growth in Germany
                                   TABLE 95 GERMANY: CANCER INCIDENCE, BY TYPE, 2018 VS. 2025
                                   TABLE 96 GERMANY: KEY MACROINDICATORS
                                   TABLE 97 GERMANY: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                   TABLE 98 GERMANY: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 99 GERMANY: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 100 GERMANY: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)S
                                   TABLE 101 GERMANY: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                                   TABLE 102 GERMANY: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.3.3 SWEDEN
                       10.3.3.1 Increasing government initiatives and deployment of digital pathology solutions
                                   TABLE 103 SWEDEN: CANCER CASES, 2018
                                   TABLE 104 SWEDEN: KEY MACROINDICATORS
                                   TABLE 105 SWEDEN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025(USD MILLION)
                                   TABLE 106 SWEDEN: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 107 SWEDEN: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 108 SWEDEN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 109 SWEDEN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                                   TABLE 110 SWEDEN: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.3.4 DENMARK
                       10.3.4.1 High cancer prevalence to drive the market growth in Denmark
                                   FIGURE 31 DENMARK: CANCER PREVALENCE, 2012–2020
                                   TABLE 111 DENMARK: KEY MACROINDICATORS
                                   TABLE 112 DENMARK: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                   TABLE 113 DENMARK: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 114 DENMARK: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 115 DENMARK: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 116 DENMARK: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                                   TABLE 117 DENMARK: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.3.5 FRANCE
                       10.3.5.1 Increasing incidence of cancer to drive the market growth during the forecast period
                                   TABLE 118 FRANCE: CANCER INCIDENCE, BY TYPE, 2018 VS. 2025
                                   TABLE 119 FRANCE: KEY MACROINDICATORS
                                   TABLE 120 FRANCE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                   TABLE 121 FRANCE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 122 FRANCE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 123 FRANCE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 124 FRANCE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                                   TABLE 125 FRANCE: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.3.6 REST OF EUROPE (ROE)
                       TABLE 126 ROE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                       TABLE 127 ROE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                       TABLE 128 ROE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                       TABLE 129 ROE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
                       TABLE 130 ROE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                       TABLE 131 ROE: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
     10.4 ASIA PACIFIC
               TABLE 132 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
               TABLE 133 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
               TABLE 134 ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
               TABLE 135 ASIA PACIFIC: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
               TABLE 136 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
               TABLE 137 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
               TABLE 138 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
               TABLE 139 ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018–2025 (USD MILLION)
               TABLE 140 ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018–2025 (UNITS)
             10.4.1 CHINA
                       10.4.1.1 Favorable initiatives for the adoption of telepathology in China
                                   TABLE 141 CHINA: CANCER CASES, 2018
                                   TABLE 142 CHINA: KEY MACROINDICATORS
                                   TABLE 143 CHINA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                   TABLE 144 CHINA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 145 CHINA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 146 CHINA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 147 CHINA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                                   TABLE 148 CHINA: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.4.2 JAPAN
                       10.4.2.1 Increasing initiatives by industry players for cancer diagnosis to drive market growth
                                   TABLE 149 JAPAN: KEY MACROINDICATORS
                                   TABLE 150 JAPAN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                   TABLE 151 JAPAN: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 152 JAPAN: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 153 JAPAN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 154 JAPAN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                                   TABLE 155 JAPAN: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.4.3 INDIA
                       10.4.3.1 Growing number of cancer cases in India to drive the market growth
                                   TABLE 156 INDIA: KEY MACROINDICATORS
                                   TABLE 157 INDIA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                   TABLE 158 INDIA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 159 INDIA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 160 INDIA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 161 INDIA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                                   TABLE 162 INDIA: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.4.4 REST OF ASIA PACIFIC (ROAPAC)
                                   TABLE 163 ROAPAC: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                   TABLE 164 ROAPAC: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 165 ROAPAC: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 166 ROAPAC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 167 ROAPAC: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                                   TABLE 168 ROAPAC: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
     10.5 REST OF THE WORLD
               TABLE 169 ROW: DIGITAL PATHOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
               TABLE 170 ROW: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
               TABLE 171 ROW: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
               TABLE 172 ROW: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
               TABLE 173 ROW: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
               TABLE 174 ROW: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
               TABLE 175 ROW: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
               TABLE 176 ROW: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018–2025 (USD MILLION)
               TABLE 177 ROW: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018–2025 (UNITS)
             10.5.1 LATIN AMERICA
                       10.5.1.1 Increasing purchasing power and healthcare affordability to drive the market growth in Latin America
                                   TABLE 178 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                   TABLE 179 LATIN AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 180 LATIN AMERICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 181 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 182 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                                   TABLE 183 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.5.2 MIDDLE EAST & AFRICA
                       10.5.2.1 Infrastructural developments in the region to support market growth
                                   TABLE 184 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                   TABLE 185 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 186 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 187 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   TABLE 188 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
                                   TABLE 189 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 160)
     11.1 INTRODUCTION
     11.2 MARKET EVALUATION FRAMEWORK
               FIGURE 32 MARKET EVALUATION FRAMEWORK: PARTNERSHIPS AND COLLABORATIONS WERE THE MOST WIDELY ADOPTED STRATEGIES
     11.3 MARKET SHARE ANALYSIS
               FIGURE 33 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
     11.4 DIGITAL PATHOLOGY MARKET: GEOGRAPHICAL ASSESSMENT
               FIGURE 34 GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN THE DIGITAL PATHOLOGY MARKET (2019)
     11.5 DIGITAL PATHOLOGY MARKET: R&D EXPENDITURE
               FIGURE 35 R&D EXPENDITURE OF KEY PLAYERS IN THE DIGITAL PATHOLOGY MARKET (2019)
     11.6 COMPETITIVE SCENARIO
             11.6.1 KEY DEVELOPMENTS IN THE DIGITAL PATHOLOGY MARKET
                       TABLE 190 PARTNERSHIPS & COLLABORATIONS (JANUARY 2017–SEPTEMBER 2020)
             11.6.2 KEY PRODUCT LAUNCHES
                       TABLE 191 PRODUCT LAUNCHES (JANUARY 2017–SEPTEMBER 2020)
             11.6.3 KEY EXPANSIONS
                       TABLE 192 EXPANSIONS (JANUARY 2017–SEPTEMBER 2020)

12 COMPANY EVALUATION MATRIX & COMPANY PROFILES (Page No. - 165)
     12.1 COMPANY EVALUATION MATRIX DEFINITION & METHODOLOGY
     12.2 COMPANY EVALUATION MATRIX
             12.2.1 STARS
             12.2.2 EMERGING LEADERS
             12.2.3 PERVASIVE
             12.2.4 PARTICIPANTS
                       FIGURE 36 DIGITAL PATHOLOGY MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019
     12.3 COMPETITIVE LEADERSHIP MAPPING: STARTUPS/SMES
             12.3.1 PROGRESSIVE COMPANIES
             12.3.2 STARTING BLOCKS
             12.3.3 RESPONSIVE COMPANIES
             12.3.4 DYNAMIC COMPANIES
                       FIGURE 37 COMPETITIVE LEADERSHIP MAPPING OF THE DIGITAL PATHOLOGY MARKET: STARTUPS/SMES
     12.4 COMPANY PROFILES
(Business overview, Products offered, Recent developments & MnM View)*
             12.4.1 LEICA BIOSYSTEMS
                       FIGURE 38 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
             12.4.2 KONINKLIJKE PHILIPS
                       FIGURE 39 KONINKLIJKE PHILIPS: COMPANY SNAPSHOT (2019)
             12.4.3 HAMAMATSU PHOTONICS
                       FIGURE 40 HAMAMATSU PHOTONICS: COMPANY SNAPSHOT (2019)
             12.4.4 F. HOFFMANN-LA ROCHE LTD.
                       FIGURE 41 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2019)
             12.4.5 SECTRA AB
                       FIGURE 42 SECTRA AB: COMPANY SNAPSHOT (2019)
             12.4.6 3DHISTECH
             12.4.7 APOLLO ENTERPRISE IMAGING CORP.
             12.4.8 XIFIN, INC.
             12.4.9 HURON DIGITAL PATHOLOGY
             12.4.10 VISIOPHARM
             12.4.11 CORISTA
             12.4.12 INDICA LABS
             12.4.13 OBJECTIVE PATHOLOGY SERVICES
             12.4.14 OPTRASCAN, INC.
             12.4.15 GLENCOE SOFTWARE, INC.
             12.4.16 PAIGE
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
     12.5 OTHER COMPANIES
             12.5.1 PATHAI
             12.5.2 KONFOONG BIOTECH INTERNATIONAL CO., LTD.
             12.5.3 INSPIRATA, INC.
             12.5.4 MIKROSCAN TECHNOLOGIES, INC.
             12.5.5 PROSCIA, INC.
             12.5.6 KANTERON SYSTEMS

13 APPENDIX (Page No. - 202)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the digital pathology market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the digital pathology market. The primary sources from the demand side included industry experts, purchase & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.

A breakdown of the primary respondents is provided below:

Digital Pathology Market  Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the digital pathology market was arrived at after data triangulation from two different approaches, as mentioned below.

Approach to calculate the revenue of different players in the digital pathology market

The size of the global digital pathology market was obtained from annual reports, SEC filings, online publications, and extensive primary interviews. A percentage split was applied to arrive at the size of market segments. Further splits were applied to arrive at the size for each sub-segment. These percentage splits were validated by primary participants. The country-level market sizes obtained from the annual reports, SEC filings, online publications, and extensive primary interviews were added up to reach the total market size for regions. By adding up the market sizes for all the regions, the global digital pathology market was derived.

Approach to derive the market size and estimate market growth

The market size and market growth were estimated through primary interviews on a regional and global level. All responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.

Data Triangulation

After arriving at the overall market size—using the market size estimation processes explained above—the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Objectives of the Study

  • To define, describe, and forecast the global digital pathology market by product, type, application, end user, and region
  • To provide detailed information about the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall digital pathology market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the digital pathology market in four major regions along with their respective key countries (North America, Europe, Asia, and the Rest of the World)
  • To profile the key players in the global digital pathology market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as product launches, expansions, and R&D activities of the leading players in the digital pathology market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis

  • Further breakdown of the digital pathology market into South Korea, New Zealand, and other Southeast Asian countries
  • Further breakdown of the European digital pathology market into Italy, Spain, Belgium, and the Netherlands.
COVID-19

Get in-depth analysis of the COVID-19 impact on the Digital Pathology Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Digital Pathology Market

Request For Special Pricing
Report Code
HIT 2608
Published ON
Oct, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Digital Pathology Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2020 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home